Neuro-Auto-Immune Disease Diagnostics Market

Future Market Insights

Key Insight

The neuro-auto-immune disease diagnostics market is projected to grow from USD 2.0 billion in 2025 to USD 4.0 billion by 2035, at a CAGR of 7.4%. Antinuclear Antibodies (ANA) Test will dominate with a 32.2% market share, while hospitals will lead the end user segment with a 55.8% share.

October 09, 2025

Anurag Sharma

260 Pages

Cite this Report

Neuro-Auto-Immune Disease Diagnostics Market

https://www.futuremarketinsights.com/reports/neuro-auto-immune-disease-diagnostics-market

License

Starting at US$ 5000

Buy Now

Summary ToC Companies

Key Players

Abbott Diagnostics Inc
Beckman Coulter
Bio-Rad Laboratories
Crescendo Bioscience
Euroimmun
Quest Diagnostics
Hoffmann-La Roche
SQI Diagnostic

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Neuro-Auto-Immune Disease Diagnostics Market

Key Players

Similar Industry Reports